Cytomics, the human cytome project and systems biology: Top-down resolution of the molecular biocomplexity of organisms by single cell analysis

Cell Proliferation

Volumn 38, Issue 4, 2005, Pages 171-174

  Valet, Günter ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGY; CELL FUNCTION; CELL PH; CYTOMETRY; GENOMICS; MEMBRANE POTENTIAL; METABOLOMICS; PHENOTYPE; PROTEOMICS;

COMPUTATIONAL BIOLOGY; CYTOLOGICAL TECHNIQUES; CYTOLOGY; CYTOPHOTOMETRY; DRUG DESIGN; EUKARYOTIC CELLS; FLOW CYTOMETRY; HUMANS; IMAGE CYTOMETRY; SYSTEMS BIOLOGY;

EID: 23844456571     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2005.00342.x     Document Type: Article

References (37)

1. Arkhipov SN, Berezovski M, Jitkova J, Krylov SN (2005) Chemical cytometry for monitoring metabolism of a Rasmimicking substrate in single cells. Cytometry Part A 63 A, 41.
2. Bocsi J, Varga VS, Molnar B, Sipos F, Tulassay Z, Tarnok A (2004) Related scanning fluorescent microscopy analysis is applicable for absolute and relative cell frequency determinations. Cytometry Part A 61A, 1.
3. Camargo FD, Chambers SM, Goodell MA (2004) Stem cell plasticity: from transdifferentiation to macrophage fusion. Cell Prolif. 31, 55.
4. Casasnovas RO, Slimane FK, Garand R, Faure GC, Campos L, Deneys V, Bernier M, Falkenrodt A, Lecalvez G, Maynadié M, Béné MC (2003) Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Leukemia 17, 515.
5. Collins FS, Green ED, Guttmacher AE, Guyer MS (2003) A vision of the future of genomic research. Nature 422, 835.
6. Dovichi NJ, Hu S (2003) Chemical cytometry. Curr Opin Chem Biol 7, 603.
7. Ecker RC, Tarnok A (2005) Cytomics goes 3D: towards cytomics. Cytometry Part A 65A, 1.
8. Ecker RC, de Martin R, Steiner GE (2004a) Microscopy-based multicolor tissue cytometry at the single cell level. Cytometry Part A 59A, 182.
9. Ecker RC, de Martin R, Steiner GE, Schmid JA (2004b) Application of spectral imaging microscopy in cytomics and fluorescence eneregy transfer (FRET) analysis. Cytometry Part A 59A, 172.
10. Edwards BS, Oprea T, Prossnitz ER, Sklar LA (2004) Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 8, 392.
11. George TC, Basiji DA, Hall BE, Lynch DH, Ortyn WE, Perry DJ, Seo MJ, Zimmerman CA, Morrissey PJ (2004) Distingusihing modes of cell death using the ImageStream multispectral imaging flow cytometer. Cytometry Part A 59A, 237.
12. Gerstner AOH, Müller AK, Machlitt J, Tárnok A, Tannapfel A, Weber A, Bootz F (2003) Slide-based cytometry for predicting malignancy in solid salivary gland tumors by fine needle aspirate biopsies. Cytometry Part B Clin Cytom 53B, 20.
13. Gerstner AO, Trumpfheller C, Racz P, Osmancik P, Tenner-Racz K, Tarnok A (2004) Quantitative histology by multicolor slide-based cytometry. Cytometry Part A 59A, 210.
14. Grygierzec W, Deutsch A, Philipsen L, Friedenberger M, Schubert W (2004) Modelling tumor cell population dynamics based on molecular adhesion assumptions. J Biol Systems 12, 273.
15. Habib LK, Finn WG (2005) Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia. Cytometry in press.
16. Hood L (2003) Systems biology: integrating technology, biology, and computation. Mech Ageing Dev 124, 9.
17. Kantor AB, Alters SE, Cheal K, Dietz LJ (2004) Immune systems biology: immunoprofiling of cell and molecules. BioTechniques 36, 520.
18. Kelley R, Ideker T (2005) Systematic interpretation of genetic interactions using protein networks. Nat Biotechnol 23, 561.
19. Kriete A, Boyce K (2005) Automated tissue analysis - a bioinformatics perspective. Methods Inf Med 44, 32.
20. Maynadié M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G, Campos L, Dromelet A, Lepelley P, Jouault H, Imbert M, Rosenwadj M, Vergé V, Bissière P, Raphaël M, Béné MC, Feuillard J, Groupe d'Etude Immunologique des Leucémies (GEIL) (2002) Immunophenotypic clustering of myelodysplastic syndromes. Blood 100, 2349.
21. Melnikova I (2005) Future of COX2 inhibitors. Nat Rev Drug Discov 4, 453.
22. Mittag A, Lenz D, Gerstner AOH, Sack U, Steinbrecher M, Koksch M, Raffael A, Bocsi J, Tárnok A (2005) Polychromatic (eight-color) slide-based cytometry for the phenotyping of leukocytes, NK andf NKT subsets. Cytometry Part A 65 A, 103.
23. Palkova Z, Vachova L, Valer M, Preckel T (2004) Single-cell analysis of yeast, mammalian cells, and fungal spores with a microfluidic pressure-driven chip-based system. Cytometry Part A 59A, 246.
24. Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ (2004) Multidimensional drug profiling by automated microscopy. Science 306, 1194.
25. Psaty BM, Furberg CD, Ray WA, Weiss NS (2004) Potential for conflict of interest in the evaluation of suspected adverse drug reactions: Use of cerivastatin and risk of rhabdomyolysis. JAMA 292, 2622.
26. Rippon HJ, Bishop AE (2004) Embryonic stem cells. Cell Prolif 37, 23.
27. Sams-Dodd F (2005) Target-based drug discovery: is something wrong? DDT 10, 139.
28. Schneider M (2004) A rational approach to maximize success rate in target discovery. Arch Pharm 337, 625.
29. Schubert W (1990) Multiple antigen-mapping microscopy of human tissue. In: Burger G, Oberholzer M, Vooijs GP, eds. Advances in Analytical Cellular Pathology. Excerpta Medica, Amsterdam, p. 97.
30. Schubert W (2004) Exploring the toponome: localize hundred proteins (or more) at once and walk through protein networks, cell by cell. Cytometry Part A 64A, 117.
31. Taylor TB, Nambiar PR, Raja R, Cheung E, Rosenberg DW, Anderegg B (2004) Microgenomics: identification of new expression profiles via small and single-cell sample analysis. Cytometry Part A 59A, 254.
32. Valet G (2005) Human cytome project, cytomics and systems biology: the incentive for new horizons in cytometry. Cytometry Part A 64A, 1.
33. Valet GK, Tarnok A (2003b) Cytomics in predictive medicine. Cytometry Part B Clin Cytom 53B, 1.
34. Valet G, Leary JF, Tarnok A (2004) Cytomics - new technologies: towards a human cytome project. Cytometry Part A 59A, 167.
35. Valet G, Repp R, Link H, Ehninger G, Gramatzki M, SHG-AML Study Group (2003a) Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters. Cytometry Part B Clin Cytom 53B, 4.
36. Weston AD, Hood L (2004) Systems biology, proteomics, and the future of health care: towards predictive, preventatitve, and personalized medicine. J. Proteome Res. 3, 179.
37. Wu H, Wheeler A, Zare RN (2004) Chemical cytometry on a picoliter-scale integrated microfluidic chip. PNAS 101, 12809.